M.J. Crees

TL;DR: In this article , the authors investigated anti-spike IgG antibody responses and correlates of protection after second doses of ChAdOx1 or BNT162b2 vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

TL;DR: In a nationally representative UK community study, the COVID-19 Infection Survey, the authors investigated symptoms in polymerase chain reaction (PCR)-positive infection episodes versus PCR-negative study visits over calendar time, by age and vaccination status, comparing periods when the Delta, Omicron BA.1, and BA.2 variants were dominant.

TL;DR: The results were considered to be favourable for the use of deltamethrin in malaria control by means of residual house-spraying with the non-irritant dosage of 15 mg/m2, but require evaluation in larger trials.

TL;DR: The authors evaluated whether a single vaccination in individuals who have already been infected with SARS-CoV-2 generates similar initial and subsequent antibody responses to two vaccinations in those without prior infection.

TL;DR: In this paper , the behavioural effects of vaccination against SARS-CoV-2 (COVID-19) are well documented, yet the behavioral effects not well known, such as socialising, commuting, and working outside the home.